Multivariate Endpoint, Disease Progress Model and Other New Features of the DIAN-TU Platform Trial Guoqiao Wang, Washington University in St Louis; Scott Berry, Berry Consultants; Chengjie Xiong, Washington University in St Louis; Jason Hassenstab, Washington University in St Louis; Melanie Quintana, Berry Consultants; Eric McDade, Washington University in St Louis; Paul Delmar, F. Hoffmann-La Roche Ltd; Matteo Vestrucci, University of Texas at Austin; Randall Bateman, Washington University in St Louis; Andrew Aschenbrenner, Washington University in St Louis
10:45 AM
TRCPAD: Accelerating Participant Recruitment in Alzheimer’s Disease Clinical Trials Using Machine Learning Techniques Oliver Langford, University of Southern California; Michael C Donohue, University of Southern California; Gustavo Jimenez-Maggiora, University of Southern California; Reisa Sperling, Harvard Medical School; Jeff Cummings, Cleveland Clinic Lou Ruvo Center for Brain Health; Paul S Aisen, University of Southern California; Rema C Raman, University of Southern California
